Cerus competitors

Zippia score 4.7

Cerus main competitors are Alder Biopharmaceuticals, Halozyme, and Promega.

Competitor Summary. See how Cerus compares to its main competitors:

Haemonetics has the most employees (3,300).
Employees at Alder Biopharmaceuticals earn more than most of the competitors, with an average yearly salary of $94,428.

Work at Cerus?

Share your experience

Cerus vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Cerus	1991	4.7	Concord, CA	1	$201.3M	254
Haemonetics	1971	4.6	Braintree Town, MA	6	$1.3B	3,300
Taiga Biotech	2006	3.7	Aurora, CO	1	$1.2M	15
Hemostemix	2006	3.3	-	-	$284.9K	8
BioTime	1990	3.4	Alameda, CA	1	$3.4M	101
Cell Vault	2019	3.5	Daytona Beach, FL	1	$71,000	1
Signature Science	2001	4.4	Austin, TX	1	$42.0M	350
Invitro	-	3.8	New York, NY	1	$710,000	25
Alder Biopharmaceuticals	2004	4.4	Bothell, WA	2	$6.5M	202
Digene Corporation	1985	4.3	Gaithersburg, MD	1	$29.0M	200
ABC Laboratories	1968	4.2	Columbia, MD	1	$72.0M	3,000
Promega	1978	4.7	Madison, WI	2	$450.0M	1,601
Halozyme	1998	4.8	San Diego, CA	1	$1.0B	136
Cornerstone Pharmaceuticals	2000	3.4	New York, NY	1	$890,000	30

Rate how well Cerus differentiates itself from its competitors.

Cerus salaries vs competitors

Among Cerus competitors, employees at Alder Biopharmaceuticals earn the most with an average yearly salary of $94,428.

Compare Cerus salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Cerus	$74,464	$35.80	-
Haemonetics	$64,516	$31.02	-
Taiga Biotech	$45,529	$21.89	-
Hemostemix	$45,003	$21.64	-
BioTime	$50,309	$24.19	-
Cell Vault	$44,823	$21.55	-

Compare Cerus job title salaries vs competitors

Company	Highest salary	Hourly salary
Cerus	$80,846	$38.87
Halozyme	$107,154	$51.52
Promega	$85,466	$41.09
BioTime	$84,554	$40.65
ABC Laboratories	$82,835	$39.82
Invitro	$82,540	$39.68
Haemonetics	$81,977	$39.41
Cornerstone Pharmaceuticals	$81,793	$39.32
Signature Science	$80,521	$38.71
Taiga Biotech	$80,446	$38.68
Alder Biopharmaceuticals	$80,071	$38.50
Hemostemix	$80,018	$38.47
Cell Vault	$79,901	$38.41
Digene Corporation	$79,668	$38.30

Do you work at Cerus?

Does Cerus effectively differentiate itself from competitors?

Cerus jobs

Cerus demographics vs competitors

Compare gender at Cerus vs competitors

Job title	Male	Female
Haemonetics	63%	37%
Cerus	-	-

Male

Female

100%

75%

50%

25%

Cerus

Haemonetics

25%

50%

75%

100%

Compare race at Cerus vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Haemonetics	63%	15%	8%	11%	3%	9.9

Cerus revenue vs competitors

Cerus revenue is $201.3M. Among it's competitors, the company with the highest revenue is Haemonetics, $1.3B . The company with the lowest revenue is Cell Vault, $71.0K.

Cerus and similar companies CEOs

CEOBio

Paul Cleveland

Alder Biopharmaceuticals

Brian Culley

BioTime

Experienced public company CEO determined to leave the world a healthier place than when he arrived by developing new treatments for serious diseases and conditions.

Christopher A. Simon

Haemonetics

Chris Simon is a President and Chief Executive Officer at Haemonetics and Board Member at Haemonetics and is based in Braintree, Massachusetts. He has worked as Senior Partner at McKinsey & Company, Hospital Supply and Scientific Products at Baxter Healthcare Corporation, and Infantry Officer at United States Army. Christopher attended The Wharton School between 1981 and 1985 and Harvard Business School between 1991 and 1993.

W. Richard Ulmer

Invitro

John D. Bucksath

ABC Laboratories

Adam L. Hamilton

Signature Science

Thomas A. Smeenk

Hemostemix

Thomas Smeenk is a President/CEO at Tyranex Gold Inc, Director at Hemostemix Inc, and Board Member at Hemostemix Inc and is based in Toronto, Ontario, Canada. He has worked as Dir:Business Development at Bullion Management Group Inc, Founder & President also Vice-President Business Development at Theravitae, and VP:Business Development at Memex Inc.. Thomas works or has worked as President/CEO at Ibi Corp. He studied at Western University between 1986 and 1988, CCH between 1975 and 1979, and Carleton University between 1983 and 1985.

Yosef Refaeli

Taiga Biotech